UPSC Civil Services · Science & Technology · Question 39 of 98

UPSC Prelims 2022 GS Paper 1, Question 39: answer and solution

Source: UPSC — official question paper (PDF)official answer key (PDF)

Questions: official UPSC paperAnswers: official keyExplanations: AI-assisted, checked by How we checkReport a mistake

In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements :

  • 1.The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform.
  • 2.Sputnik V vaccine is manufactured using vector based platform.
  • 3.COVAXIN is an inactivated pathogen based vaccine.

Which of the statements given above are correct ?

  • A1 and 2 only
  • B2 and 3 only
  • C1 and 3 only
  • D1, 2 and 3

Correct answer: (B) 2 and 3 only

Statement 1 is wrong: Covishield, the Oxford-AstraZeneca vaccine made by the Serum Institute of India, uses a non-replicating chimpanzee adenovirus vector (ChAdOx1). It is not an mRNA vaccine. mRNA vaccines are ones such as Pfizer-BioNTech and Moderna. Statement 2 is correct: Sputnik V uses two human adenovirus vectors (Ad26 and Ad5), so it is a vector-based vaccine. Statement 3 is correct: Bharat Biotech's COVAXIN uses whole SARS-CoV-2 virus that has been killed (inactivated).

Try the whole UPSC Prelims 2022 GS Paper 1 paper as a timed test

98 questions, the real time limit, then a full debrief: your rank among PadhoDost students, mistake types and what to fix.

Start the timed test

More UPSC questions on Science & Technology

All UPSC Science & Technology questions, every year →